Theratechnologies TSX TH
$1.80 0.0000 0.0000%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

170.90M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

210.57M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.75
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

94.95M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-15.89 %
Upcoming events Theratechnologies All events
No upcoming events scheduled

Stock chart Theratechnologies

Stock analysis Theratechnologies

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-6.94 -6.94
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
53.01 3.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-18.70 7.80
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-3.52 2.11
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-70.05 -1.04

Price change Theratechnologies per year

2.43$ 5.34$
Min Max

Summary analysis Theratechnologies

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Theratechnologies

Revenue and net income Theratechnologies

All parameters
Stock news Theratechnologies All news

Theratechnologies Shares Sink at Open After FDA Rejects Newer Tesamorelin Formulation

Theratechnologies Shares Sink at Open After FDA Rejects Newer Tesamorelin Formulation

Theratechnologies Shares Slide Premarket as FDA Turns Away Newer Egrifta

Theratechnologies Shares Slide Premarket as FDA Turns Away Newer Egrifta

Theratechnologies: FDA Rejects Newer Egrifta Formulation

Theratechnologies: FDA Rejects Newer Egrifta Formulation

Theratechnologies Shares Fall as FDA Continues to Review License Application for Tesamorelin

Theratechnologies Shares Fall as FDA Continues to Review License Application for Tesamorelin

Toronto Stocks Down; Theratechnologies Falls After Going Concern Warning

Toronto Stocks Down; Theratechnologies Falls After Going Concern Warning

Theratechnologies Warns of Going Concern Uncertainty

Theratechnologies Warns of Going Concern Uncertainty

Theratechnologies Shares Drop 12% on Reverse Stock Split

Theratechnologies Shares Drop 12% on Reverse Stock Split

Theratechnologies in 1-for-4 Reverse Stock Split

Theratechnologies in 1-for-4 Reverse Stock Split

Theratechnologies Shares Drop 16% as Weaker HIV Drug Sales Drag on 2Q Revenue

Theratechnologies Shares Drop 16% as Weaker HIV Drug Sales Drag on 2Q Revenue

Theratechnologies Sets Path to Resume TH1902 Clinical Development

Theratechnologies Sets Path to Resume TH1902 Clinical Development

About company Theratechnologies

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Address:
Company name: Theratechnologies
Issuer ticker: TH
Country: USA
Exchange: TSX
Currency: $
Sector: Energy
Industry: Oil & Gas Equipment & Services
Site:

On which stock exchange are Theratechnologies (TH) stocks traded?

Theratechnologies (TH) stocks are traded on TSX.

What is the ticker of Theratechnologies stocks (TH)?

The stock ticker of Theratechnologies’s stocks or in other words, the code is TH. The stocks are currently listed on the TSX exchange.

In which sector and industry does Theratechnologies (TH) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Theratechnologies (TH) belongs to the «Energy» sector and the «Oil & Gas Equipment & Services» industry.

In what currency are Theratechnologies (TH) stocks traded?

Theratechnologies (TH) stocks are traded on the TSX exchange in dollars.

What is the price of Theratechnologies (TH) stocks today?

The current price of Theratechnologies stocks on 29.04.2024 is 1.8 dollars. per share.

What is the dynamics of Theratechnologies (TH) stocks from the beginning of the year?

Theratechnologies (TH) quotes have increased by -20% from the beginning of the year up to 1.8 dollars. per 1 stocks.

How much did Theratechnologies (TH) stocks increase in апреле 2024?

This month Theratechnologies (TH) quotes have increased by -15.49% to 1.8 dollars. per share.

How much are Theratechnologies (TH) stocks worth?

Today, on October, 29.04.2024 Theratechnologies’s (TH) stocks cost 1.8 dollars..

What is the market capitalization of Theratechnologies (TH)?

Capitalization is the market value of Theratechnologies (TH) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Theratechnologies (TH) is estimated at about 170901250 dollars.